Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Skin substitutes & wound grafts · New York | Skin substitutes & wound grafts · New Jersey | |
|---|---|---|
| Surgeons, 2024 | 70 | 47 |
| Medicare fee-for-service cases | 14,481 | 11,826 |
| Growth since 2019 (Medicare FFS) | +3.3%/yr | +17%/yr |
| Forecast cases (Medicare FFS) | 20,500 in 2030 | 21,200 in 2030 |
| Forecast growth | +5.9%/yr to 2030 | +10%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 4.7 | 7.7 |
| Medicare Advantage share | 57% | 45% |
| Out of hospital | 45% (+24 pts since 2019) | 65% (+38 pts since 2019) |
| Cases per surgeon | 207 | 252 |
| Top 10 surgeons' share | 39% | 53% |
| Surgeons growing | 1 | 6 |
| New since the base year | 43 | 33 |
| Likely to stop billing it | 34 by 2026 | 24 by 2026 |
| Forecast miss, 1 year (procedure) | 5% | 5% |
| Company payments per surgeon | $20K | $15K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.